Announcements Trials

Browse Landscape

Phase

Status

Unknown 11 Completed 3 Active not recruiting 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1

Conditions

Colonic Neoplasms 1

Interventions

Oxaliplatin 197 Bevacizumab 162 Fluorouracil 155 Capecitabine 137 Gemcitabine 133 Leucovorin 112 pembrolizumab 99 Cisplatin 93 Drug Therapy 89 Irinotecan 81 Radiotherapy 73 sintilimab 70 durvalumab 65 130-nm albumin-bound paclitaxel 65 Paclitaxel 64 Specimen Handling 62 Cetuximab 61 lenvatinib 59 tislelizumab 58 Nivolumab 55 Magnetic Resonance Spectroscopy 55 Folfox protocol 55 Blood Specimen Collection 52 atezolizumab 48 Biopsy 46 Surgical Procedures, Operative 40 Taxes 38 Albumin-Bound Paclitaxel 38 Immune Checkpoint Inhibitors 37 HMPL-013 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Conversion to Open Surgery × Gastrointestinal × Clear all

NCT07314996 2026-06-03

LOVO

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡